start portlet menu bar end portlet menu bar

Efficacy of ICTHIOVAC® VR against Listonella anguillarum serovar O2α in European sea bass fry and juveniles

Inicio Conocimiento Efficacy of ICTHIOVAC® VR against Listonella anguillarum serovar O2α in European sea bass fry and juveniles

Efficacy of ICTHIOVAC® VR against Listonella anguillarum serovar O2α in European sea bass fry and juveniles

European Sea Bass (Dicentrarchus labrax) is a marine fish species with a high commercial value, especially in the Mediterranean countries and Europe. Vibriosis caused by Listonella (Vibrio) anguillarum is a common disease in Sea Bass that has led to significant economic losses to date. Therefore, development and use of preventive strategies can evade these associated mortalities [1].

Descarga este artículo

4,75 MB

Sobre este artículo

Autores

Ruiz, M. C.; Robles, R.; Callol, C.; Colomer, S.; Vendrell, D.; Perelló, M. Bermúdez, L.

Resumen

Clear differences in the mortality rates between vaccinated and control groups were observed. The mortality rates reported in vaccinated groups ranged between 21.67 and 22.22 % whereas the mortality rates in control groups were of 60-97.78 %. Deaths were observed between 24 and 72 hours after challenge.

Servicios relacionados

HIPRA Diagnos

Productos relacionados

ICTHIOVAC® VR

Publicaciones relacionadas

Safety and efficacy of an inactivated vaccine against Lactococcus garvieae in rainbow trout (Oncorhynchus mykiss) Lactococcus garvieae in fish: A review

Compartir en

start portlet menu bar

Efficacy of ICTHIOVAC® VR against Listonella anguillarum serovar O2α in European sea bass fry and juveniles

Display portlet menu
end portlet menu bar

Ver también

Publicaciones

Efficacy of ICTHIOVAC® VR/PD against Listonella anguillarum in sea bass under unfavorable ...

12-09-2018
Fichas de enfermedades

Lactococcosis in trout

12-01-2017
Noticia

HIPRA en WE’R AQUACULTURE 2018, Montpellier

13-09-2018